ZaÄtseva EA et al. |
[Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis]. |
1996 |
Antibiot. Khimioter. |
pmid:8762820
|
Iakovlev SV and Ukhin SA |
[Azithromycin: general properties and regimen optimization based on pharmacokinetic and pharmacological parameters]. |
2003 |
Antibiot. Khimioter. |
pmid:12803047
|
Gomberg MA and MashkilleÄson AL |
[Use of azithromycin in long existing urogenital chlamydia infections and its association with primary syphilis]. |
1993 |
Antibiot. Khimioter. |
pmid:8060178
|
Sidorenko SV |
[Azithromycin--an antibiotic of the azalide group]. |
1993 |
Antibiot. Khimioter. |
pmid:8060181
|
Lopatkin NA et al. |
[Use of azithromycin ("Sumamded") in the treatment of infectious-inflammatory diseases of the lower urinary tract and male genitalia]. |
1993 |
Antibiot. Khimioter. |
pmid:8060189
|
Bingen E et al. |
Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821495
|
Pettus K et al. |
In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25624328
|
Retsema J et al. |
Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2449865
|
Beringer P et al. |
Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16304166
|
Ulrich M et al. |
Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against streptococcus pneumoniae in vitro when administered up to 6 hours after challenge. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16304181
|
Saiz JC and MartÃn-Acebes MA |
Reply to Iannetta et al., "Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells". |
2017 |
Antimicrob. Agents Chemother. |
pmid:28839084
|
Girard AE et al. |
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2830841
|
Iannetta M et al. |
Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28839081
|
Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Hammerschlag MR et al. |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324650
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Marchisio P et al. |
Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124831
|
Seyama S et al. |
Amino Acid Substitution in the Major Multidrug Efflux Transporter Protein AcrB Contributes to Low Susceptibility to Azithromycin in Haemophilus influenzae. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28848006
|
Tateda K et al. |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891128
|
Kemp MW et al. |
Maternal intravenous administration of azithromycin results in significant fetal uptake in a sheep model of second trimester pregnancy. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25155606
|
Hunt Gerardo S et al. |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8891154
|
Zheng S et al. |
Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25155592
|
Engel JN |
Azithromycin-induced block of elementary body formation in Chlamydia trachomatis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1280057
|
Saini H et al. |
Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28031194
|
Walsh M et al. |
In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:3038010
|
Starner TD et al. |
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms. |
2008 |
Antimicrob. Agents Chemother. |
pmid:17954687
|
Turcinov D et al. |
Failure of azithromycin in treatment of Brill-Zinsser disease. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817744
|
Tsitsika A et al. |
Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817749
|
Bin XX et al. |
Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10817751
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Pacifico L et al. |
Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849215
|
Zasowski E et al. |
Relationship between time to clinical response and outcomes among Pneumonia Outcomes Research Team (PORT) risk class III and IV hospitalized patients with community-acquired pneumonia who received ceftriaxone and azithromycin. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24752270
|
Wong MH et al. |
Emergence of clinical Salmonella enterica serovar Typhimurium isolates with concurrent resistance to ciprofloxacin, ceftriaxone, and azithromycin. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24752251
|
Marvig RL et al. |
Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22644032
|
Beale AS and Upshon PA |
Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid, or azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7811001
|
Chinh NT et al. |
A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858343
|
Schwab JC et al. |
Localization of azithromycin in Toxoplasma gondii-infected cells. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979295
|
Allen GP and Harris KA |
Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28483960
|
Caronzolo D et al. |
Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561871
|
Carter G et al. |
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15561879
|
Roord JJ et al. |
Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124837
|
Wenisch C et al. |
Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878577
|
Gnarpe J et al. |
In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843291
|
Dreses-Werringloer U et al. |
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11600348
|
Tateda K et al. |
Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11353657
|
Gödeke J et al. |
Recycling of peptidyl-tRNAs by peptidyl-tRNA hydrolase counteracts azithromycin-mediated effects on Pseudomonas aeruginosa. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23318806
|
Nagaoka K et al. |
Macrolides inhibit Fusobacterium nucleatum-induced MUC5AC production in human airway epithelial cells. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23380724
|
Bergman KL et al. |
Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223956
|
Akova M et al. |
In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223958
|